ReviewF1000Research2019

Developing better drugs for pulmonary sarcoidosis: determining indications for treatment and endpoints to assess therapy based on patient and clinician concerns.

Marc A JudsonPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.